ROIV   $9.01  2.93% Market Closed

Roivant Sciences Ltd
Total Cash 6.67B
totalCashPerShare 8.278
EBITDA -1.03B
Total Debt 506.58M
quickRatio 27.497
currentRatio 27.794
Total Revenue 123.24M
debtToEquity 7.693
Revenue/Share 0.16
ROA -0.13768
ROE 1.05802
grossProfits
freeCashflow -502.47M
operatingCashflow -835.90M
earningsGrowth
revenueGrowth 1.178
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -7.74171
profitMargins 36.24138
enterpriseValue 3.07B
forwardPE -9.086207
floatShares 353.40M
sharesOutstanding 805.85M
sharesShort 31.57M
sharesShortPriorMonth 28.77M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.62%
Short Ratio help_outline 6.07%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 7.566
Price To Book help_outline 1.39
earningsQuarterlyGrowth
netIncomeToCommon 4.35B
trailingEps 5.27%
forwardEps -1.16%
enterpriseToEbitda -2.99
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 1Q 2024
institutionsCount 311
lastUpdated April 1, 2024, 3:25 p.m.